CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma.
Oncotarget. 2019 Dec 17;10(66):7058-7070. doi: 10.18632/oncotarget.27361. eCollection 2019 Dec 17.
Oncotarget. 2019.
PMID: 31903165
Free PMC article.